Axogen
$19.439876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$19.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.02 (+5.54%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Axogen and other stocks, options, and ETFs commission-free!
About AXGN
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL. The listed name for AXGN is Axogen, Inc. Common Stock.
CEO
Karen L. Zaderej
Employees
394
Headquarters
Alachua, Florida
Founded
1977
Market Cap
789.22M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
296.66K
High Today
$19.62
Low Today
$18.35
Open Price
$18.50
Volume
381.47K
52 Week High
$20.83
52 Week Low
$7.16
Collections
Analyst Ratings
71%
of 7 ratings
Buy
71%
Hold
29%
Sell
0%
AXGN Earnings
-$0.38
-$0.24
-$0.10
$0.04
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 22, After Hours